|
1 |
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma
Garcia-Marquez, Maria A.. - Würzburg : Universität Würzburg, 2025
|
|
|
|
2 |
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP
Jachimowicz, Ron Daniel. - Würzburg : Universität Würzburg, 2025
|
|
|
|
3 |
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
Damaschin, Carla. - Würzburg : Universität Würzburg, 2024
|
|
|
|
4 |
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group
Eichenauer, Dennis A.. - Würzburg : Universität Würzburg, 2024
|
|
|
|
5 |
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
Thurner, Lorenz. - Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2023
|
|
|
|
6 |
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Fuchs, Michael. - Ulm : Universität Ulm, 2023
|
|
|
|
7 |
Low B‐cell content is associated with a CD73 ‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma
Grund, Johanna. - Kiel : Universitätsbibliothek Kiel, 2023
|
|
|
|
8 |
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
Oertel, Michael. - Münster : Universitäts- und Landesbibliothek Münster, 2023
|
|
|
|
9 |
Radiotherapy in the GHSG HD 16 and HD 17 trials – quality assurance and dosimetric analysis for Hodgkin lymphoma in the modern era
Oertel, Michael. - Münster : Universitäts- und Landesbibliothek Münster, 2023
|
|
|
10 |
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Enthalten in Leukemia 16.10.2023: 1-8
|
|
Administration
